Immortal time bias in the study of effectiveness of interferon-β in multiple sclerosis

被引：19
|
作者：
Renoux, Christel [1 ]
Suissa, Samy
机构：
[1] McGill Univ, Ctr Hlth, Div Clin Epidemiol, Dept Epidemiol & Biostat, Montreal, PQ, Canada
来源：
ANNALS OF NEUROLOGY | 2008年 / 64卷 / 01期
关键词：
D O I：
10.1002/ana.21352
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：109 / 110
页数：2
相关论文
共 50 条
  • [41] Effects of glatiramer acetate and interferon-β on neurodegeneration in a model of multiple sclerosis -: A comparative study
    Maier, Katharina
    Kuhnert, Antje V.
    Taheri, Naimeh
    Saettler, Muriel B.
    Storch, Maria K.
    Williams, Sarah K.
    Baehr, Mathias
    Diem, Ricarda
    AMERICAN JOURNAL OF PATHOLOGY, 2006, 169 (04): : 1353 - 1364
  • [42] Pharmacogenetic study of long-term response to interferon-β treatment in multiple sclerosis
    Clarelli, F.
    Liberatore, G.
    Sorosina, M.
    Osiceanu, A. M.
    Esposito, F.
    Mascia, E.
    Santoro, S.
    Pavan, G.
    Colombo, B.
    Moiola, L.
    Martinelli, V.
    Comi, G.
    Martinelli-Boneschi, F.
    PHARMACOGENOMICS JOURNAL, 2017, 17 (01): : 84 - 91
  • [43] Pharmacogenetic study of long-term response to interferon-β treatment in multiple sclerosis
    F Clarelli
    G Liberatore
    M Sorosina
    A M Osiceanu
    F Esposito
    E Mascia
    S Santoro
    G Pavan
    B Colombo
    L Moiola
    V Martinelli
    G Comi
    F Martinelli-Boneschi
    The Pharmacogenomics Journal, 2017, 17 : 84 - 91
  • [44] Interferon-β1b in the treatment of multiple sclerosis
    Río, J
    Montalban, X
    EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (16) : 2877 - 2886
  • [45] Improving Compliance with Interferon-β Therapy in Patients with Multiple Sclerosis
    Portaccio, Emilio
    Amato, Maria Pia
    CNS DRUGS, 2009, 23 (06) : 453 - 462
  • [46] How Does Interferon-β Really Work in Multiple Sclerosis?
    Mitsdoerffer, Meike
    Kuchroo, Vijay
    ANNALS OF NEUROLOGY, 2009, 65 (05) : 487 - 488
  • [47] Interferon-β1b for the treatment of multiple sclerosis
    Lam, Sum
    Wang, Shan
    Gottesman, Malcolm
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2008, 4 (08) : 1111 - 1117
  • [48] Evaluation of biomarkers for the response to interferon-β treatment in multiple sclerosis
    Jensen, Poul Erik H.
    Sellebjerg, Finn
    Krakauer, Martin
    Ryder, Lars P.
    Alsing, Ingrid
    Hesse, Dan
    Koch-Henriksen, Nils
    Svejgaard, Arne
    Sorensen, Per Soelbeig
    MULTIPLE SCLEROSIS, 2008, 14 : S128 - S128
  • [49] Gene expression analysis of interferon-β treatment in multiple sclerosis
    Sellebjerg, F.
    Datta, P.
    Larsen, J.
    Rieneck, K.
    Alsing, I.
    Oturai, A.
    Svejgaard, A.
    Sorensen, P. Soelberg
    Ryder, L. P.
    MULTIPLE SCLEROSIS JOURNAL, 2008, 14 (05) : 615 - 621
  • [50] Interferon-β therapy and risk of thrombocytopenia in multiple sclerosis patients
    Tatiana Koudriavtseva
    Domenico Plantone
    Rosaria Renna
    Chiara Mandoj
    Diana Giannarelli
    Caterina Mainero
    Neurological Sciences, 2015, 36 : 2263 - 2268
12345